Zhejiang Wenda Pharma reports positive NHWD-870 HCl oral BET inhibitor Phase II trial results at 2026 ESMO Annual Meeting

Bio-Thera reports promising BAT8008 - BAT1308 combination lung cancer clinical data at ESMO 2026

Lunit and Summit to apply AI-powered SCOPE IO platform for tumour microenvironment analysis in immuno-oncology development

Zai Lab reports promising Phase 1b results for zocilurtatug pelitecan in small cell lung cancer

HUYABIO International reports positive Phase 3 trial results for HBI-8000 and nivolumab combination

ImmunoForge to participate in BIO-Europe 2026

IHI and Bristol Myers Squibb launch initiative to expand cancer clinical trial access

Summit Therapeutics and ECOG-ACRIN launch Phase II/III trial collaboration for biliary tract cancer

Abbott secures CE Mark for Cologuard Plus in Europe

Oracle partners AstraZeneca for AI-enabled healthcare innovation

Telix and Ekalia to develop US astatine-211 production

GSK reports 61% response rate for investigational lung cancer drug

IBA and Framatome establish joint venture to scale up Astatine-211 production

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC